Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Syracuse › NPI 1871710038
Agency

Syracuse Model Neighborhood Facility, INC

Syracuse Model Neighborhood Facility, INC was paid $1.69M by Medicaid between Jan 2018 and Apr 2022, across 27 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 38% of everything it billed.

33Billing provider infoSYRACUSE MODEL NEIGHBORHOOD FACILITY, INC
SYRACUSE, NY 13204
33aNPI1871710038assigned 04/19/2007
28Total paid$1.69M
24GClaims46,218
24DCodes billed27
24AFirst – last monthJan 2018 – Apr 2022
Compared with peers

Next to other Public Health or Welfare Agency providers in New York

Rank by total paid#8 of 41
Median peer was paid$114K
This provider vs. median15×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201811,823$352K
20199,849$328K
202010,650$449K
202111,099$450K
20222,797$114K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 38% 8,067 3,794 $636K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 21% 4,153 2,027 $347K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 14% 3,422 1,370 $243K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 7.8% 4,549 4,501 $132K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 5.9% 4,549 4,499 $100K
99385 3.4% 1,040 339 $58K
J1050 Injection, medroxyprogesterone acetate, 1 mg 1.8% 1,997 1,959 $30K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.5% 2,085 2,076 $25K
88142 1.4% 865 865 $23K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1.3% 260 142 $22K
86703 1.1% 1,825 1,822 $18K
81025 <1% 5,807 5,657 $16K
15 more codes
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies <1% 25 $10K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 318 $8K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 41 $7K
99406 <1% 147 $6K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 204 $3K
36415 Collection of venous blood by venipuncture <1% 431 $3K
87210 <1% 3,484 $2K
S4993 Contraceptive pills for birth control <1% 169 $2K
85018 <1% 1,505 $780.43
81002 <1% 567 $234.00
86780 <1% 446 $205.02
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 101 $144.85
99051 <1% 13 $131.19
87088 <1% 131 $18.35
86803 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHROEDER, SAMANTHA (DIRECTOR OF FINANCIAL OPERATIONS)